DBV Technologies S.A. (DBV.PA)
EUR 1.52
(-4.28%)
EUR 1.52
(-4.28%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.71 EUR | 42.74% |
| 2022 | -1.24 USD | 30.34% |
| 2021 | -1.78 USD | 39.66% |
| 2020 | -2.95 EUR | 36.56% |
| 2019 | -4.65 EUR | 29.22% |
| 2018 | -6.57 EUR | 8.24% |
| 2017 | -7.16 EUR | -45.23% |
| 2016 | -4.93 EUR | -117.18% |
| 2015 | -2.27 EUR | -24.73% |
| 2014 | -1.82 EUR | 7.14% |
| 2013 | -1.96 EUR | -40.0% |
| 2012 | -1.40 EUR | -100.0% |
| 2011 | -0.70 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.28 USD | -133.33% |
| 2024 Q2 | -0.34 USD | -21.43% |
| 2023 Q1 | -0.24 USD | 42.86% |
| 2023 FY | - EUR | 42.74% |
| 2023 Q4 | -0.12 USD | 29.41% |
| 2023 Q3 | -0.17 USD | 34.62% |
| 2023 Q2 | -0.26 USD | -8.33% |
| 2022 Q3 | -0.18 USD | 47.06% |
| 2022 Q4 | -0.42 USD | -133.33% |
| 2022 Q1 | -0.30 USD | -20.0% |
| 2022 Q2 | -0.34 USD | -13.33% |
| 2022 FY | - USD | 30.34% |
| 2021 Q1 | -0.54 USD | 25.0% |
| 2021 Q2 | -0.56 USD | -3.7% |
| 2021 Q3 | -0.44 USD | 21.43% |
| 2021 Q4 | -0.25 USD | 43.18% |
| 2021 FY | - USD | 39.66% |
| 2020 Q1 | -0.79 USD | 14.13% |
| 2020 Q3 | -0.56 USD | 36.36% |
| 2020 FY | - EUR | 36.56% |
| 2020 Q4 | -0.72 USD | -28.57% |
| 2020 Q2 | -0.88 USD | -11.39% |
| 2019 FY | - EUR | 29.22% |
| 2019 Q4 | -0.92 EUR | -64.29% |
| 2019 Q1 | -1.36 USD | -34.65% |
| 2019 Q2 | -1.38 USD | -1.47% |
| 2019 Q3 | -0.56 EUR | 59.42% |
| 2018 FY | - EUR | 8.24% |
| 2018 Q4 | -1.01 EUR | -8.6% |
| 2018 Q3 | -0.93 EUR | 38.82% |
| 2018 Q2 | -1.52 USD | 5.0% |
| 2018 Q1 | -1.60 USD | 12.09% |
| 2017 Q2 | -1.68 USD | -7.01% |
| 2017 Q3 | -1.79 USD | -6.55% |
| 2017 Q4 | -1.82 USD | -1.68% |
| 2017 FY | - EUR | -45.23% |
| 2017 Q1 | -1.57 USD | -12.14% |
| 2016 Q1 | -1.16 USD | -65.71% |
| 2016 FY | - EUR | -117.18% |
| 2016 Q4 | -1.40 USD | 6.04% |
| 2016 Q3 | -1.49 USD | -31.86% |
| 2016 Q2 | -1.13 USD | 2.59% |
| 2015 Q1 | -0.34 USD | 22.73% |
| 2015 FY | - EUR | -24.73% |
| 2015 Q4 | -0.70 USD | 2.78% |
| 2015 Q3 | -0.72 USD | -53.19% |
| 2015 Q2 | -0.47 USD | -38.24% |
| 2014 Q4 | -0.44 USD | 4.35% |
| 2014 FY | - EUR | 7.14% |
| 2014 Q1 | -0.48 USD | 15.79% |
| 2014 Q2 | -0.59 USD | -22.92% |
| 2014 Q3 | -0.46 USD | 22.03% |
| 2013 Q2 | -0.38 USD | 0.0% |
| 2013 Q3 | -0.56 USD | -47.37% |
| 2013 Q4 | -0.57 USD | -1.79% |
| 2013 FY | - EUR | -40.0% |
| 2013 Q1 | -0.38 USD | -2.7% |
| 2012 Q3 | -0.36 USD | 0.0% |
| 2012 FY | - EUR | -100.0% |
| 2012 Q4 | -0.37 USD | -2.78% |
| 2011 FY | - EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| ABIONYX Pharma SA | -0.12 EUR | -491.667% |
| ABIVAX Société Anonyme | -3.43 EUR | 79.3% |
| Adocia SA | -1.91 EUR | 62.827% |
| Aelis Farma SA | -0.39 EUR | -82.051% |
| Biophytis S.A. | -12.55 EUR | 94.343% |
| Advicenne S.A. | -0.67 EUR | -5.97% |
| genOway Société anonyme | 0.17 EUR | 517.647% |
| IntegraGen SA | -0.03 EUR | -2641.313% |
| Medesis Pharma S.A. | -0.80 EUR | 11.25% |
| Neovacs S.A. | -0.00 EUR | -28300.0% |
| NFL Biosciences SA | -0.46 EUR | -54.348% |
| Plant Advanced Technologies SA | 0.07 EUR | 1114.286% |
| Quantum Genomics Société Anonyme | -0.09 EUR | -680.22% |
| Sensorion SA | -0.17 EUR | -317.647% |
| Theranexus Société Anonyme | -0.88 EUR | 19.318% |
| TME Pharma N.V. | -1.34 EUR | 47.015% |
| Valbiotis SA | -0.59 EUR | -20.339% |
| TheraVet SA | -0.49 EUR | -44.898% |
| Valerio Therapeutics Société anonyme | -0.15 EUR | -373.333% |
| Genfit S.A. | -0.58 EUR | -22.414% |
| GeNeuro SA | -0.59 EUR | -20.339% |
| Innate Pharma S.A. | -0.09 EUR | -654.516% |
| Inventiva S.A. | -2.43 EUR | 70.782% |
| MaaT Pharma SA | -1.73 EUR | 58.96% |
| MedinCell S.A. | -0.88 EUR | 19.318% |
| Nanobiotix S.A. | -1.08 EUR | 34.259% |
| OSE Immunotherapeutics SA | -1.18 EUR | 39.831% |
| Poxel S.A. | -0.91 EUR | 21.978% |
| GenSight Biologics S.A. | -0.54 EUR | -31.481% |
| Transgene SA | -0.22 EUR | -222.727% |
| Valneva SE | -0.73 EUR | 2.74% |